Logo image of FONR

FONAR CORP (FONR) Stock Fundamental Analysis

NASDAQ:FONR - US3444374058 - Common Stock

15.88 USD
+0.06 (+0.38%)
Last: 8/28/2025, 4:30:01 PM
Fundamental Rating

5

FONR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While FONR has a great health rating, its profitability is only average at the moment. FONR has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

FONR had positive earnings in the past year.
In the past year FONR had a positive cash flow from operations.
Each year in the past 5 years FONR has been profitable.
FONR had a positive operating cash flow in each of the past 5 years.
FONR Yearly Net Income VS EBIT VS OCF VS FCFFONR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

With a decent Return On Assets value of 3.68%, FONR is doing good in the industry, outperforming 78.92% of the companies in the same industry.
FONR has a Return On Equity of 4.60%. This is in the better half of the industry: FONR outperforms 76.22% of its industry peers.
FONR has a Return On Invested Capital of 4.51%. This is in the better half of the industry: FONR outperforms 74.59% of its industry peers.
The Average Return On Invested Capital over the past 3 years for FONR is in line with the industry average of 8.44%.
Industry RankSector Rank
ROA 3.68%
ROE 4.6%
ROIC 4.51%
ROA(3y)4.96%
ROA(5y)4.84%
ROE(3y)6.44%
ROE(5y)6.47%
ROIC(3y)7.14%
ROIC(5y)7.07%
FONR Yearly ROA, ROE, ROICFONR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 7.67%, FONR is in the better half of the industry, outperforming 78.92% of the companies in the same industry.
FONR's Profit Margin has declined in the last couple of years.
FONR has a better Operating Margin (11.68%) than 77.30% of its industry peers.
In the last couple of years the Operating Margin of FONR has declined.
FONR has a worse Gross Margin (41.23%) than 66.49% of its industry peers.
In the last couple of years the Gross Margin of FONR has declined.
Industry RankSector Rank
OM 11.68%
PM (TTM) 7.67%
GM 41.23%
OM growth 3Y-5.46%
OM growth 5Y-8.71%
PM growth 3Y-3.38%
PM growth 5Y-10.22%
GM growth 3Y-3.21%
GM growth 5Y-2.4%
FONR Yearly Profit, Operating, Gross MarginsFONR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FONR is destroying value.
FONR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, FONR has about the same amount of shares outstanding.
Compared to 1 year ago, FONR has an improved debt to assets ratio.
FONR Yearly Shares OutstandingFONR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
FONR Yearly Total Debt VS Total AssetsFONR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 2.73 indicates that FONR is not a great score, but indicates only limited risk for bankruptcy at the moment.
FONR has a Altman-Z score of 2.73. This is in the better half of the industry: FONR outperforms 67.57% of its industry peers.
FONR has a debt to FCF ratio of 0.06. This is a very positive value and a sign of high solvency as it would only need 0.06 years to pay back of all of its debts.
The Debt to FCF ratio of FONR (0.06) is better than 94.59% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that FONR is not too dependend on debt financing.
FONR's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. FONR outperforms 70.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.06
Altman-Z 2.73
ROIC/WACC0.51
WACC8.86%
FONR Yearly LT Debt VS Equity VS FCFFONR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

FONR has a Current Ratio of 10.05. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.
FONR has a Current ratio of 10.05. This is amongst the best in the industry. FONR outperforms 93.51% of its industry peers.
A Quick Ratio of 9.86 indicates that FONR has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 9.86, FONR belongs to the best of the industry, outperforming 93.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.05
Quick Ratio 9.86
FONR Yearly Current Assets VS Current LiabilitesFONR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for FONR have decreased strongly by -21.19% in the last year.
Measured over the past years, FONR shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.12% on average per year.
FONR shows a small growth in Revenue. In the last year, the Revenue has grown by 0.29%.
FONR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.36% yearly.
EPS 1Y (TTM)-21.19%
EPS 3Y1.78%
EPS 5Y-7.12%
EPS Q2Q%37.05%
Revenue 1Y (TTM)0.29%
Revenue growth 3Y4.6%
Revenue growth 5Y3.36%
Sales Q2Q%5.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FONR Yearly Revenue VS EstimatesFONR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.57 indicates a correct valuation of FONR.
89.19% of the companies in the same industry are more expensive than FONR, based on the Price/Earnings ratio.
FONR is valuated cheaply when we compare the Price/Earnings ratio to 27.17, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.57
Fwd PE N/A
FONR Price Earnings VS Forward Price EarningsFONR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FONR is valued cheaply inside the industry as 98.92% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, FONR is valued cheaply inside the industry as 95.68% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.49
EV/EBITDA 2.61
FONR Per share dataFONR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FONR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FONAR CORP

NASDAQ:FONR (8/28/2025, 4:30:01 PM)

15.88

+0.06 (+0.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-19 2025-05-19
Earnings (Next)09-25 2025-09-25
Inst Owners48.71%
Inst Owner Change-3.74%
Ins Owners5.07%
Ins Owner Change0%
Market Cap100.52M
Analysts0
Price TargetN/A
Short Float %0.92%
Short Ratio2.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.57
Fwd PE N/A
P/S 0.98
P/FCF 12.49
P/OCF 8.63
P/B 0.58
P/tB 0.61
EV/EBITDA 2.61
EPS(TTM)1.17
EY7.37%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.27
FCFY8.01%
OCF(TTM)1.84
OCFY11.58%
SpS16.27
BVpS27.15
TBVpS25.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.68%
ROE 4.6%
ROCE 5.99%
ROIC 4.51%
ROICexc 6.18%
ROICexgc 6.51%
OM 11.68%
PM (TTM) 7.67%
GM 41.23%
FCFM 7.81%
ROA(3y)4.96%
ROA(5y)4.84%
ROE(3y)6.44%
ROE(5y)6.47%
ROIC(3y)7.14%
ROIC(5y)7.07%
ROICexc(3y)9.85%
ROICexc(5y)9.62%
ROICexgc(3y)10.45%
ROICexgc(5y)10.24%
ROCE(3y)9.49%
ROCE(5y)9.41%
ROICexcg growth 3Y-5.28%
ROICexcg growth 5Y-14.37%
ROICexc growth 3Y-4.76%
ROICexc growth 5Y-13.51%
OM growth 3Y-5.46%
OM growth 5Y-8.71%
PM growth 3Y-3.38%
PM growth 5Y-10.22%
GM growth 3Y-3.21%
GM growth 5Y-2.4%
F-Score6
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.06
Debt/EBITDA 0.01
Cap/Depr 64.01%
Cap/Sales 3.49%
Interest Coverage 388.27
Cash Conversion 65.96%
Profit Quality 101.82%
Current Ratio 10.05
Quick Ratio 9.86
Altman-Z 2.73
F-Score6
WACC8.86%
ROIC/WACC0.51
Cap/Depr(3y)68.94%
Cap/Depr(5y)98.58%
Cap/Sales(3y)3.32%
Cap/Sales(5y)4.6%
Profit Quality(3y)113.41%
Profit Quality(5y)133.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.19%
EPS 3Y1.78%
EPS 5Y-7.12%
EPS Q2Q%37.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.29%
Revenue growth 3Y4.6%
Revenue growth 5Y3.36%
Sales Q2Q%5.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.92%
EBIT growth 3Y-1.11%
EBIT growth 5Y-5.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-26.36%
FCF growth 3Y-4.82%
FCF growth 5Y-3.64%
OCF growth 1Y-24.06%
OCF growth 3Y-9.62%
OCF growth 5Y-6.24%